Melanoma/Skin Trials
R2810-ONC-1788 | A Randomized Phase III Placebo controlled Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma (cSCC). |
R2810-ONC-1788 | A Randomized Phase III Placebo controlled Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma (cSCC). |
MON | 7:30am - 5:00pm |
TUE | 7:30am - 5:00pm |
WED | 7:30am - 5:00pm |
THU | 7:30am - 5:00pm |
FRI | 7:30am - 5:00pm |
SAT | closed |
SUN | closed |
After Hours Emergency: Please access your local hospital emergency department.